Skip to main content
Clinical Trials/NCT01184469
NCT01184469
Completed
Not Applicable

Prospective Observational Study of Peri-implantation Serum hCG Levels

Bruce Shapiro M.D.1 site in 1 country451 target enrollmentAugust 2010
ConditionsInfertility

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Infertility
Sponsor
Bruce Shapiro M.D.
Enrollment
451
Locations
1
Primary Endpoint
Ongoing pregnancy
Status
Completed
Last Updated
13 years ago

Overview

Brief Summary

The purpose of this study is to prospectively define a set of data suitable for developing models of pregnancy viability. Those models will be based on serum hCG concentration measured during the peri-implantation period in patients that received fresh embryo transfer and those that received transfer of frozen-thawed embryos, and to compare and contrast these models. This may reveal insights into differences between these types of IVF cycles.

Detailed Description

The current study seeks to examine the effect of the timing of implantation (as indicated by the first increase in serum hCG level) on the viability of pregnancies and to determine if such effect of timing differs between fresh embryo transfers and frozen-thawed embryos transfers. In this case, the timing of implantation will be measured through serum hCG analysis on days 3, 4, 5, and 7 after blastocyst transfer.

Registry
clinicaltrials.gov
Start Date
August 2010
End Date
May 2012
Last Updated
13 years ago
Study Type
Observational
Sex
Female

Investigators

Sponsor
Bruce Shapiro M.D.
Responsible Party
Sponsor Investigator
Principal Investigator

Bruce Shapiro M.D.

Medica Director

Fertility Center of Las Vegas

Eligibility Criteria

Inclusion Criteria

  • IVF patients (adults) who received blastocyst transfer

Exclusion Criteria

  • Those patients using different laboratories

Outcomes

Primary Outcomes

Ongoing pregnancy

Time Frame: 10 weeks gestation

Fetal heart motion at 10 weeks gestation.

Study Sites (1)

Loading locations...

Similar Trials